ImPassion130 Trial Outcomes

obr has 860 videos Subscribe Here

Description: Debu Tripathy, MD, Professor and Chair, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center shares the results of ImPassion130, a phase III study adding atezolizumab to the 1st line chemotherapy with nab-paclitaxel in patients with PD-L1 positive metastatic triple-negative breast cancer (TNBC).
Shared By : obr
Posted on : 07/02/19
Added : 15 days ago
Category : Breast Cancer